Related Experiment Video
Updated: Jun 23, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
Management of side effects of sirolimus therapy
Giovanni Stallone1, Barbara Infante, Giuseppe Grandaliano
1Department of Biomedical Sciences, Section of Nephrology, University of Foggia, Foggia, Italy. g.stallone@unifg.it
Abstract:
Sirolimus (SRL) has been shown to improve long-term graft survival in several calcineurin inhibitor avoidance/minimization protocols. Although SRL has been suggested to reduce the progression of chronic renal graft damage and to prevent the development of neoplasia, two of the most prominent challenges in the field of transplantation, its use is significantly limited by an extremely high incidence of side effects. Some of the side effects are directly linked to the antiproliferative action of SRL, whereas the mechanisms underlying most of the undesired effects of the drug are still far from being clarified. Nevertheless, there is an increasing body of evidence linking most these drug-associated events to SRL dose. In addition, it is now possible to identify well-defined risk factors for most of these effects. Thus, to limit SRL-related side effects the two golden rules are (1) accurate selection of patients to be treated and (2) avoidance of high SRL doses.
Insights
Sirolimus improves graft survival but causes side effects. Careful patient selection and avoiding high doses are key to minimizing these adverse events in transplantation.
Area of Science:
- Transplantation immunology
- Pharmacology
Background:
- Sirolimus (SRL) enhances long-term graft survival in transplantation.
- SRL may reduce chronic renal damage and prevent neoplasia.
- High incidence of side effects limits SRL use.
Purpose of the Study:
- To review the role of Sirolimus in transplantation.
- To discuss the mechanisms and dose-dependency of SRL side effects.
- To identify strategies for mitigating SRL-associated adverse events.
Main Methods:
- Literature review of Sirolimus in transplantation protocols.
- Analysis of studies on SRL side effects and their mechanisms.
- Evaluation of patient selection and dosing strategies.
Main Results:
- Sirolimus demonstrates benefits in graft survival and may prevent renal damage and neoplasia.
- Many side effects are linked to SRL's antiproliferative action and drug dosage.
- Patient selection and dose minimization are crucial for managing side effects.
Conclusions:
- Sirolimus is a valuable agent in transplantation, but its use requires careful management.
- Understanding the dose-related nature of side effects is critical.
- Optimizing patient selection and avoiding high Sirolimus doses are essential strategies.
Related Concept Videos
Kidney Transplant III: Nursing Management
Nephrotic Syndrome III : Nursing Management
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Myocarditis IV: Nursing Management
Nephrotic Syndrome II : Assessment and Medical Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
